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Abstract
A standardized mortality review of hospital autopsies identified discrepancies between clinical diagnoses and autopsy findings,
unexpected deaths, adequacy of diagnostic workup, presence of adverse event, and type of a quality issue if present. The stan-
dardized review elements were chosen based on a review of quality metrics commonly used by hospitals. The review was
completed by the pathologist based on their initial autopsy findings. The final autopsy report was later reviewed to confirm the
initial review findings. Major discrepancies in diagnosis were categorized as class I or II based on the modified Goldman criteria.
Ninety-six hospital autopsy cases from January 2015 to February 2018 were included in the study. The overall major discrepancy
rate was 27%. Class I discrepancies, where a diagnosis found at autopsy might have improved survival had it been made pre-
mortem, were identified in 16% of cases. Categories associated with increased discrepancy rates included unexpected deaths,
inadequate workup, abnormal labs or imaging not addressed, and certain quality issues. Deaths not expected at admission but
expected at the time of death, those with adverse events, those within 48 hours of a procedure, those within 48 hours of
admission, those with physician-specific quality issues, and those with system or process issues were not significantly related to
diagnostic accuracy.
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Introduction
The rate of hospital autopsies has been declining in the United
States in recent decades.1 Estimated at only 8% in 2003, the
autopsy rate has shown a dramatic drop compared to the esti-
mated 30% to 40% in the 1960s.1-3 Factors often cited for the
decline include high cost and lack of direct reimbursement,
lack of defined minimum rate standards for hospitals, overcon-
fidence in diagnostic testing, and concerns over malpractice
litigation.4,5 Yet despite this decline, the autopsy has demon-
strated its importance in quality improvement, medical educa-
tion, identifying new diseases or new manifestations of known
diseases, evaluating the effect of treatments such as immu-
notherapy in some cancers, and compiling accurate public
health data.6
One way the autopsy serves as a quality control measure is
by revealing incorrect or missed diagnoses. This clinico-
autopsy discrepancy rate has been estimated to be as high as
30% in recent studies.4,7 Analysis of pre- and postmortem dis-
crepancies can be helpful for identifying areas of weakness in
clinical diagnostic capability. For example, previous studies
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have identified pulmonary embolism as one of the most com-
monly missed diagnoses, suggesting that further prophylactic
measures or lower threshold for suspicion may be indicated.
Previous studies have also analyzed specific age groups, med-
ical units (especially intensive care units), underlying diseases,
and length of stay in order to identify groups with higher risk
for significant discrepancy.
As autopsy rates continue to decline and missed diagnoses
continue to be significant, proposals on how to firmly integrate
the autopsy into hospital quality improvement processes and
analysis of unexpected mortality, system errors, and clinical
decision-making will be essential. This pilot study provides a
means to achieve this integration through a standardized mor-
tality review process.
Methods
Creating the Mortality Review Form
A mortality review form for hospital autopsies was created by
an attending pathologist to address elements of the University
Health System Consortium risk-adjusted mortality model using
the following resource as a guide: https://www.ahrq.gov/sites/
default/files/wysiwyg/professionals/systems/hospital/qitoolkit/
combined/d4n_combo_iqi-mortalityreview-bestpractices.pdf.
The 1-page form (Figure 1) includes demographic data,
admitting diagnosis and diagnosis at the time of death, addi-
tional autopsy diagnoses, screening questions related to unex-
pected mortality, diagnostic workup, time of death related to
admission, and adverse events. The form also identifies physi-
cian or system quality issues and the type of quality issue and,
if the quality issue was related to patient evaluation, decision-
making, communication, supervision, professionalism, or other
factors. Unexpected death was defined as any mortality in a
patient for whom, based on clinical findings at the time of
admission, recovery and/or hospital discharge was the antici-
pated outcome.
The Pilot Study
The mortality review form was completed by board-certified
pathologists based on medical record review and their pre-
liminary findings at autopsy. Cases included in this study
were adult hospital autopsy cases performed between Janu-
ary 2015 and June 2018 at Vidant Medical Center in Green-
ville, North Carolina. All cases had autopsy consent from
the legal next of kin. Each autopsy was performed by
pathology residents and/or attending pathologists, with
supervision by the attending pathologist in each case per-
formed by a resident. The study design was reviewed and
approved by the institutional review board.
Identifying and Classifying Diagnostic Discrepancies
A review of the final autopsy report was conducted for each
case to validate the initial mortality review, with adjustments
made based on the microscopic findings, as well as to
determine the rate of discrepancy between clinical diagnoses
and autopsy findings. The medical chart was reviewed if the
clinical history in the final autopsy report was unclear or insuf-
ficient. Discrepancies were classified using the modified Gold-
man criteria.1,8-11 We focused only on major diagnoses,
meaning those related to the primary cause of death or principal
underlying disease. Major diagnostic discrepancies can be clas-
sified as class I or class II. Class I major diagnoses are those for
which detection and adjusted therapy could have prolonged
survival or cured the patient (eg, unsuspected myocardial
infarction in a patient presenting with chest pain). Class II
major diagnoses are those for which detection and adjusted
therapy would not have prolonged survival or cured the patient
(eg, unsuspected myocardial infarction in a patient presenting
with cardiac arrest).
Statistical Methods
The w2 test of independence was used to investigate whether
there was an association between each of the patient categories
identified in the mortality review survey and the incidence of
diagnostic discrepancies. In cases where the expected count
was too small to use the w2 test, Fisher exact test was used
instead. The SPSS program was used to run the tests. The
a level used to determine statistical significance was .05.
Results
Mortality review forms were completed on 96 adult autopsies
during the study period. Of the 96 autopsy cases that were
analyzed, 51 were from male patients and 45 were from female
patients. Ages ranged from 18 to 94 years, with a median age of
61 years. The demographics of the patients included are pre-
sented in Table 1. Two of the 96 patients died at home. The
decision was made to include these 2 individuals because both
had been admitted within 3 months of dying for reasons related
to their primary cause of death. The remaining 94 patients died
while admitted to Vidant Medical Center.
Major discrepancies were identified in 26 (27%) of the 96
total cases. Fifteen of these were categorized as class I discre-
pancies and 11 as class II discrepancies (16% and 11% of total
cases, respectively). A comparison of major underlying dis-
eases and primary causes of death as determined clinically and
at autopsy for all cases with class I discrepancies is summarized
in Table 2.
The relationship between expected or unexpected death and
discrepancy rate was examined. Death in 57 of the 96 cases was
expected (59%) and in 39 cases was unexpected (41%). The
rate of major diagnostic errors for expected death was 8%
(8 cases), and the rate for unexpected death was 19% (18
cases), which was statistically significant (P ¼ .001). All but
one of the discrepancies in expected death cases were class II
errors, whereas the majority of errors in unexpected death cases
(14/18 cases) were class I. Table 3 summarizes the patient
mortality groups and the rate of major discrepancies for each
category.
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Figure 1. Mortality review form.
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The relationship between inadequate diagnostic workup and
major discrepancies was evaluated and found to be significant.
Eight (8%) cases were said to have had inadequate workup
upon mortality review; the remaining 88 (92%) cases were
considered to have adequate workup. The rate of major errors
was 6% (6 cases) for cases with inadequate workup and 21%
(20 cases) for those with adequate workup. The major discre-
pancy rate was found to be significantly higher for cases with
inadequate workup (P¼ .005). Two-thirds of the discrepancies
in cases with inadequate workup were due to class I errors.
Whether abnormal findings, laboratory test results, or ima-
ging were addressed, premortem was also analyzed for
significance. Nine (9%) cases exhibited failure to address
abnormal findings. Of these, 7 cases (rate of 7%) had a diag-
nostic discrepancy, and 5 of them were class I errors. Alterna-
tively, the remaining 87 (91%) cases did not exhibit this failure,
and 19 (20%) of these had a diagnostic discrepancy. The asso-
ciation between failure to address abnormal test results and
major missed diagnoses was statistically significant (P¼ .001).
Of quality issues analyzed, the discrepancy rate for an issue
not otherwise specified (not a physician or system issue) was
identified in 6% of cases. Three of these were categorized as
class I. The association between this group and major discre-
pancies was statistically significant (P ¼ .044). System or pro-
cess issues were the most common quality-type issue, present
in 9 (9%) cases, and 3 of these had class I errors. This group
was not statistically significant (P¼ .058). Least common were
the physician-specific issues, present in only 3 (3%) cases. This
group was also not significant (P ¼ 1.000).
The patient quality issues identified were specifically
related to patient evaluation/data acquisition in 5 (5%) cases,
clinical decision making in 4 (4%) cases, performing a treat-
ment or a procedure in 4 (4%) cases, and communication and
coordination in 2 (2%) cases. No cases were identified as hav-
ing issues related to documentation, policy compliance, super-
vision, or professionalism. Other elements including expected
or unexpected mortality at the time of death, adverse events,
death after a procedure, and death within 48 hours of admission
did not show a statistically significant association with diag-
nostic discrepancy.
Table 1. Patient Demographics.














Table 2. Comparing Major Clinical Diagnoses and Autopsy Findings in Cases With Class I Discrepancies.*
Case No. Age/Sex Major Clinical Diagnoses Major Autopsy Findings
A1 35/F Septic shock, acute hemolytic anemia, thrombotic
thrombocytopenic purpura
Sickle beta plus (þ) thalassemia; acute splenic sequestration
crisis
A4 63/M Sepsis, diabetes, renal failure Diabetes, renal failure, pulmonary embolism (PE)
A13 59/M Cirrhosis, bronchitis Cirrhosis, ruptured broncho-aortic fistula
A14 78/M Heat exhaustion, shoulder pain Bacterial endocarditis
A15 60/F Mediastinal mass suspicious for malignancy,
sudden cardiac death
Ruptured thoracic aorta
A41 18/F Evan syndrome, acute kidney injury, pneumonia Evan syndrome, nonbacterial thrombotic endocarditis
A42 48/F Sepsis, necrotic uterine leiomyomata Pyelonephritis
A49 53/M PE, immobility secondary to severe depression
and obsessive compulsive disorder
PE, Parkinson disease
A90 42/M Influenza pneumonia complicated by intra-
alveolar hemorrhage and PE
Influenza pneumonia complicated by intra-alveolar hemorrhage, PE,
and necrotizing acute pancreatitis
A91 69/M Sepsis, methicillin-resistant Staphylococcus aureus
bacteremia, pneumonia
Pneumonia, invasive candidiasis
A69 62/F Intracranial hemorrhage Intracranial hemorrhage, PE
A75 70/F Sepsis, right heart failure, biventricular thrombi Idiopathic pulmonary fibrosis complicated by pulmonary
hypertension, heart failure, and thromboembolic disease
A82 56/M Ulcerative colitis status post proctocolectomy,
gastrointestinal hemorrhage
Small bowel obstruction complicated by perforation and
hemorrhage
A83 70/M Altered mental status, congestive heart failure PE, pneumonia, congestive heart failure
A101 58/F Congestive heart failure, cardioembolic stroke Cardiac sarcoidosis, cardioembolic stroke
Abbreviations: F, female; M, male.
*Unsuspected findings in bold.
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Discussion
The decline in hospital autopsy numbers has been driven in
part by the widely held belief among surveyed clinicians
that advances in diagnostic and imaging modalities have
rendered the autopsy obsolete.4 Despite this popular notion,
most studies on this topic have found no significant change
over time in the frequency with which the autopsy reveals
important, unsuspected findings.4,7,12-15 A single notable
exception is a meta-analysis study which found a decline
in the rate of major errors detected at autopsy in recent
decades.2 However, the study concluded that although the
rate was declining, it remained sufficiently high (8%-24%
for major errors) to warrant continued use of the autopsy as
a quality management tool.
Our pilot study demonstrates how an autopsy mortality
review form may be used to correlate diagnostic discrepancies
found at autopsy with important patient outcome and quality
indicators. In our study, diagnostic discrepancies found at
autopsy were found to be significantly associated with unex-
pected deaths, adequacy of diagnostic workup, whether abnor-
mal laboratory values were addressed, and with quality issues.
Such information provides a basis for improving processes
and patient outcomes. For example, pulmonary embolism and
infections were the most common causes of class I errors in our
study. Both are common complications in hospitalized patients
that can often be prevented with vigilant precautions. Analysis
of protocols and processes that are in place with an emphasis on
early diagnosis and prophylaxis would be expected to improve
outcomes. In a similar fashion, protocols and processes that
might assure the adequacy of the diagnostic workup and
follow-up on abnormal lab values would also be expected to
decrease significant discrepancies. Interventions such as
improved and standardized laboratory testing protocols, reflex
testing, and automated prompts could be attempted. When such
interventions are attempted, it would be important to continue
to perform the standardized autopsy mortality review, in order
to assess whether discrepancy rates were improving.
Table 3. Relationship Between Mortality Categories and Incidence of Major Diagnostic Discrepancies.
Cases With Major
Discrepancies,
No. (%), N ¼ 26
Cases With No Major
Discrepancies,
No. (%), N ¼ 70 P Value
Was this an unexpected mortality? .001
Yes 18 (69%) 21 (30%)
No 8 (31%) 49 (70%)
Was mortality not expected at admission but expected at the time of death? .618
Yes 13 (50%) 31 (44%)
No 13 (50%) 39 (56%)
Was death associated with an adverse event? 1.000
Yes 1 (4%) 4 (6%)
No 25 (96%) 66 (94%)
Was the diagnostic workup adequate? .005
Yes 20 (77%) 68 (97%)
No 6 (23%) 2 (3%)
Were abnormal findings and test results addressed? .001
Yes 19 (73%) 68 (97%)
No 7 (27%) 2 (3%)
Was death within 48 hours of a procedure? .206
Yes 4 (15%) 4 (6%)
No 22 (85%) 66 (94%)
Was death associated with a diagnostic failure? .000
Yes 10 (38%) 0 (0%)
No 16 (62%) 70 (100%)
Was death within 48 hours of admission? .319
Yes 11 (42%) 22 (31%)
No 15 (58%) 48 (69%)
Were quality issues identified? .044
Yes 4 (15%) 2 (3%)
No 22 (85%) 68 (97%)
Was a physician issue identified? 1.000
Yes 1 (4%) 2 (3%)
No 25 (96%) 68 (97%)
Was a system or process issue identified? .058
Yes 5 (19%) 4 (6%)
No 21 (81%) 66 (94%)
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The most common class II findings in our study were per-
forated bowel, myocardial infarct, and malignancy. Knowing
and analyzing this information in a standardized fashion allows
identification of diagnoses that clinical examination, routine
imaging, and standard laboratory protocols have not identified.
A focused analysis could identify opportunities for premortem
diagnosis or treatment and better outcomes.
Limitations of our study include small sample size, low
autopsy rate, and the convenience sampling method. It has been
suggested that selection bias may falsely elevate the discre-
pancy rate in autopsy studies, because clinicians are more
likely to request an autopsy for difficult cases. This may be
especially true for institutions such as ours with a low autopsy
rate9 (hospital autopsy rate at Vidant Medical Center was 6% in
2017). Interestingly though, studies have shown that clinicians
are generally not able to predict which cases will reveal a
missed diagnosis, therefore weakening this argument.16
In summary, use of a standardized autopsy mortality review
form provides a means to correlate discrepancy rates with
unexpected mortality, adequacy of laboratory testing, adequacy
of abnormal test follow-up, and quality indicators. Such corre-
lation could also be used to identify areas within the practice or
diagnostic categories where there were increased numbers of
discrepancies and to focus interventions in those areas, assuring
that the autopsy regains its importance as an essential quality
management tool.
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